prikaz prve stranice dokumenta Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?
  Download
PDF 251.58 KB
Scientific paper - Other
Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?
Diabetology, 4 (2023), 4; 553-559. https://doi.org/10.3390/diabetology4040049
Golčić, Marin; Belančić, Andrej

Cite this document

Golčić, M. & Belančić, A. (2023). Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?. Diabetology, 4. (4), 553-559. doi: 10.3390/diabetology4040049

Golčić, Marin and Andrej Belančić. "Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?." Diabetology, vol. 4, no. 4, 2023, pp. 553-559. https://doi.org/10.3390/diabetology4040049

Golčić, Marin and Andrej Belančić. "Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?." Diabetology 4, no. 4 (2023): 553-559. https://doi.org/10.3390/diabetology4040049

Golčić, M. and Belančić, A. (2023) 'Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?', Diabetology, 4(4), pp. 553-559. doi: 10.3390/diabetology4040049

Golčić M, Belančić A. Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?. Diabetology [Internet]. 2023 December 07 [cited 2024 May 27];4(4):553-559. doi: 10.3390/diabetology4040049

M. Golčić and A. Belančić, "Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?", Diabetology, vol. 4, no. 4, pp. 553-559, December 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:421839. [Accessed: 27 May 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?
AuthorMarin Golčić
AuthorAndrej Belančić
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Pharmacology)
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Oncology and Radiotherapy)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
Similar microorganisms, via similar mechanisms, play a role in the development of both pancreatic cancer (PC) and type 2 diabetes (T2D). Since the new onset of T2D is potentially one of the earliest signs of PC, it is highly plausible that a common denominator might be responsible for both, as the growth of the cancer will take a longer time to manifest compared to the insulin resistance. Although a variety of host-dependent factors and susceptibility play a role, and the mechanisms connecting the two diseases remain poorly understood, future well-designed trials should hypothesize whether a microbial intervention (modification and/or transplantation) results in a lower incidence and the better treatment of both diseases since the T2D–PC–gut microbiome interconnection seems scientifically logical.
Keywords (english)
Languageenglish
Publication typeScientific paper - Other
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleDiabetology
Numberingvol. 4, no. 4, pp. 553-559
e-ISSN2673-4540
DOIhttps://doi.org/10.3390/diabetology4040049
URN:NBNurn:nbn:hr:184:421839
Publication2023-12-07
Document URLhttps://www.mdpi.com/2673-4540/4/4/49
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution 4.0 International (CC BY 4.0) icon
Created on2023-12-08 14:06:20